PTSM: Pharmaceutical Technology Sourcing and Management, Sep 1, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Sep 1, 2010
APIs
Exploring Chiral Chemistry
By Patricia Van Arnum
Chemocatalytic and biocatalytic approaches in asymmetric synthesis help provide a pathway for producing single-enantiomer drugs.
Outsourcing
Project Managers Wanted
By Eric Langer
Relationship management is a limiting factor to growth in biomanufacturing outsourcing.
Sourcing
DCAT Conference Focuses on Procurement/Sourcing Strategies
By Patricia Van Arnum
Procurement, sourcing, and partnerships with external suppliers take on greater importance as the pharmaceutical supply chain becomes increasingly more complex and global.
CSR and Sustainability Forum
Evaluating Global Health Progress in the Millennium Development Goals
By Patricia Van Arnum
An upcoming summit will assess the progress and gaps in realizing the UN Millennium Development Goals, including outcomes from global health initiatives.
Secretary of State Clinton Outlines US Role in Global Health
By Patricia Van Arnum
Secretary of State Hillary Clinton details the progress and future direction of the US role in the Global Health Initiative.
CSR and Sustainability Forum
A roundup of developments on corporate social responsibility from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here